医学
1型糖尿病
重症监护医学
小岛
胰岛素
干细胞疗法
细胞疗法
移植
糖尿病
生物信息学
干细胞
内科学
内分泌学
遗传学
生物
作者
Neihenuo Chuzho,Neetu Mishra,Nikhil Tandon,Neeraj Kumar
标识
DOI:10.2174/1573399819666221202161259
摘要
The current standard method for type 1 diabetes (T1D) management majorly focuses on controlling blood glucose levels with exogeneous insulin administration. Recent developments have focused on finding ways to predict and prevent the development of T1D, as well as finding a curative therapy for T1D. Such developments include β-cell replacement therapy by islet transplantation, non-insulin adjunct therapy, gene and stem cell-based therapies, immunotherapy, and automated treatment with an artificial pancreas. In recent years, non-traditional alternative therapy has also become a popular treatment option for T1D. This review discusses the various therapeutic options for T1D currently under various stages of development, the challenges associated with the present strategies, and their potential to eventually change the way T1D is treated.
科研通智能强力驱动
Strongly Powered by AbleSci AI